How to Order

For additional information or to place an order, please call Customer Service at +44 (0) 19 2320 2504.

Order Information
Order Code Description Length Unit of Measure Quantity
CARTHP Emprint™ Ablation Cart   Box 1
CAGENHP Emprint™ Ablation Generator with Thermosphere™ Technology    Box 1


Emprint™ Short Percutaneous Antenna with Thermosphere™ Technology Large Spherical Ablation Zone 15 cm Box 1
CA20L2 Emprint™ Standard Percutaneous Antenna with Thermosphere™ Technology Large Spherical Ablation Zone 20 cm Box 1
CA30L2 Emprint™ Long Percutaneous Antenna with Thermosphere™ Technology Large Spherical Ablation Zone 30 cm Box 1
CAPUMP1 Emprint™ Ablation Pump   Box 1
CA190RC1 Emprint™ Ablation Reusable Cable 190 cm Box 1
RFASW Emprint™ Footswitch   Each 1
RTP20 Cool-tip™ RF Ablation Remote Temperature Probe E Series 20 cm Each 1

Order Information

Interested in Emprint™ HP demonstration?

Click the button below and request a demonstration now.

Take less healthy liver, help preserve their future6,7

Successful management of nonresectable liver tumors is about more than what you remove — it’s about what you leave behind, too. The Emprint™ ablation system enables a minimally invasive procedure that provides immediate, repeatable results4 and can help lower the chance of recurrence.8 This procedure can also be combined with additional therapies and help you give your patients a more comprehensive treatment.6

  • 1. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006 Mar;243(3):321–328.

  • 2. Hocquelet A, Balageas P, Laurent C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. Int J Hyperthermia. 2015;31(7):749–757.

  • 3. Zhang M. Ma H, Zhang J, He L, Ye X, Li X. Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta analysis. Onco Targets Ther. 2017;10:4829–4839.

  • 4. De Cobelli F, Marra P, Ratti F, et al. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol. 2017;34(4):49.

  • 5. Vogl TJ, Basten LM, Nour-Eldin A, et al. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone. Int J Hyperthermia. 2018;34(4):492–500.

  • 6. Ruers T, Van Coevorden F, Punt CJA, et al. Local treatment of unresectable colorectal liver metastases: Results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9):djx015.

  • 7. Drake TM, Harrison EM. Malignant liver tumours. Surgery. 2017;35(12):707–714.

  • 8. Takahashi H et al. Local Recurrence After Microwave Thermosphere Ablation of Malignant Liver Tumors: Results of a Surgical Series. Surgery 2018 Apr;163(4):709-713.